Search research articles
Contact Us
Filters
Showing results (31-40 of 54) with videos related to
Page
of 6
Sort By:
European Urology
|
February 7, 2025
Long-term Outcomes and Prognostic Impact of Residual Cancer Burden After Intensified Neoadjuvant Therapy in High-risk Prostate Cancer
Praful Ravi, Lucia Kwak, Andres M Acosta, et al.
Frontiers in Sports and Active Living
|
November 10, 2025
Design of debunking the frailty-sarcopenia-ADT axis in metastatic prostate cancer with multicomponent exercise: the FIERCE trial protocol
Rebekah L Wilson, Anderson Vulczak, Alicia K Morgans, et al.
The Prostate
|
April 8, 2026
Castration Resistance Accelerates Prostate Cancer Kinetics
Sheila Jonnatan, Luka Cavka, Angelo M De Marzo, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)
|
July 12, 2024
Generation and Characterization of Ex Vivo Expanded Tumor-infiltrating Lymphocytes From Renal Cell Carcinoma Tumors for Adoptive Cell Therapy
David J Einstein, Brian Halbert, Thomas Denize, et al.
Nature Communications
|
February 14, 2026
FOXJ1 mediates taxane resistance through regulation of microtubule dynamics
Fang Xie, Ada Gjyrezi, Daniel Fein, et al.
Contemporary Clinical Trials
|
June 1, 2025
Exercise to enhance cardiovascular health among black men with prostate cancer with androgen deprivation therapy (the POWER trial): A study protocol
Dong-Woo Kang, Salvatore Ficarra, Rebekah L Wilson, et al.
Cancer Research
|
February 8, 2022
Autocrine Canonical Wnt Signaling Primes Noncanonical Signaling through ROR1 in Metastatic Castration-Resistant Prostate Cancer
Fen Ma, Seiji Arai, Keshan Wang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 12, 2025
Increased ErbB2 signaling is an early adaptation to androgen signaling inhibition and persists in castration resistant prostate cancer
Jude Owiredu, Betul Ersoy-Fazlioglu, Larysa Poluben, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 25, 2021
A Subset of Localized Prostate Cancer Displays an Immunogenic Phenotype Associated with Losses of Key Tumor Suppressor Genes
Carla Calagua, Miriam Ficial, Caroline S Jansen, et al.
Cancer Research
|
November 22, 2022
Plk1 Inhibitors and Abiraterone Synergistically Disrupt Mitosis and Kill Cancer Cells of Disparate Origin Independently of Androgen Receptor Signaling
Jesse C Patterson, Andreas Varkaris, Peter J P Croucher, et al.
Page
of 6
Search research articles
Search
Showing results (31-40 of 54) with videos related to
Sort By:
Page
of 6
European Urology
|
February 7, 2025
Long-term Outcomes and Prognostic Impact of Residual Cancer Burden After Intensified Neoadjuvant Therapy in High-risk Prostate Cancer
Praful Ravi, Lucia Kwak, Andres M Acosta, et al.
Frontiers in Sports and Active Living
|
November 10, 2025
Design of debunking the frailty-sarcopenia-ADT axis in metastatic prostate cancer with multicomponent exercise: the FIERCE trial protocol
Rebekah L Wilson, Anderson Vulczak, Alicia K Morgans, et al.
The Prostate
|
April 8, 2026
Castration Resistance Accelerates Prostate Cancer Kinetics
Sheila Jonnatan, Luka Cavka, Angelo M De Marzo, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)
|
July 12, 2024
Generation and Characterization of Ex Vivo Expanded Tumor-infiltrating Lymphocytes From Renal Cell Carcinoma Tumors for Adoptive Cell Therapy
David J Einstein, Brian Halbert, Thomas Denize, et al.
Nature Communications
|
February 14, 2026
FOXJ1 mediates taxane resistance through regulation of microtubule dynamics
Fang Xie, Ada Gjyrezi, Daniel Fein, et al.
Contemporary Clinical Trials
|
June 1, 2025
Exercise to enhance cardiovascular health among black men with prostate cancer with androgen deprivation therapy (the POWER trial): A study protocol
Dong-Woo Kang, Salvatore Ficarra, Rebekah L Wilson, et al.
Cancer Research
|
February 8, 2022
Autocrine Canonical Wnt Signaling Primes Noncanonical Signaling through ROR1 in Metastatic Castration-Resistant Prostate Cancer
Fen Ma, Seiji Arai, Keshan Wang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 12, 2025
Increased ErbB2 signaling is an early adaptation to androgen signaling inhibition and persists in castration resistant prostate cancer
Jude Owiredu, Betul Ersoy-Fazlioglu, Larysa Poluben, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 25, 2021
A Subset of Localized Prostate Cancer Displays an Immunogenic Phenotype Associated with Losses of Key Tumor Suppressor Genes
Carla Calagua, Miriam Ficial, Caroline S Jansen, et al.
Cancer Research
|
November 22, 2022
Plk1 Inhibitors and Abiraterone Synergistically Disrupt Mitosis and Kill Cancer Cells of Disparate Origin Independently of Androgen Receptor Signaling
Jesse C Patterson, Andreas Varkaris, Peter J P Croucher, et al.
Page
of 6